Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients have?
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients has 424 citations in the OpenAlex counts ScholarIQ stores.
When was Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients published?
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients has 2017 year in the ScholarIQ index.
What is the open-access status of Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients?
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients has bronze oa status in the ScholarIQ index.
What is the DOI of Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients?
The DOI for Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients is on the source record.
What is the PMID of Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients?
The PMID for Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients is on the source record.
What is the OpenAlex record for Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients?
The OpenAlex for Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients is on the source record.